
|Videos|May 3, 2013
Access to Innovation
In this video, executives from AstraZeneca and MedImmune explain why access to innovation in the development of biologics is so important.
Advertisement
In this video shot at BIO International Convention 2013, executives from AstraZeneca and MedImmune explain why access to innovation in the development of biologics is so important.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Panel Unanimously Backs Moderna’s Breakthrough mRNA Flu Vaccine Amid Political Turbulence
2
Sonrotoclax Plus Zanubrutinib Achieves Undetectable MRD Rates Above 90% in Frontline CLL/SLL
3
ADA 2026: Lipid Management and Cardiovascular Prevention Updates for People With Diabetes
4
McKesson ideaShare 2026: How AI and Automation Are Reshaping the Dispensing Experience
5





















































































































